Thor Medical ASA (OSL:TRMED)
Norway · Delayed Price · Currency is NOK 4.060
-0.040 (-0.98%)
Nov 13, 2026, 4:25 PM CET
Thor Medical ASA Market Cap
Thor Medical ASA has a market cap or net worth of 1.72 billion as of November 13, 2026. It is the 21,143rd most valuable company in the world and the 136th biggest in Norway. Its market cap has increased by 30.93% in one year.
Market Cap
1.72B
Enterprise Value
1.90B
Revenue
1.64M
Global Rank
Country Rank
#136 Norway
PE Ratio
n/a
ChartMarket Cap Chart
Since July 4, 2023, Thor Medical ASA's market cap has increased from 466.61M to 1.72B, an increase of 267.62%. That is a compound annual growth rate of 47.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 1.72B | -7.72% |
| Dec 30, 2025 | 1.86B | 151.99% |
| Dec 30, 2024 | 737.69M | 144.87% |
| Dec 29, 2023 | 301.27M | -35.44% |
| Jul 4, 2023 | 466.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 2.73B |
| Nykode Therapeutics AS | 1.12B |
| ArcticZymes Technologies ASA | 1.10B |
| Lytix Biopharma ASA | 736.70M |
| Zelluna ASA | 467.32M |
| Oncoinvent ASA | 422.86M |
| SoftOx Solutions AS | 275.29M |
| Arctic Bioscience AS | 68.47M |